On May 14, 2020 The Association for Accessible Medicines (AAM) filed an amicus brief in the latest constitutional challenge to the Affordable Care Act (ACA), arguing for the survival of biosimilars pathway (BPCIA), even if the individual mandate of the ACA is found unconstitutional.
Generic and biosimilar medicines make it easier and more affordable for patients to live healthier lives.
Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.
For the latest updates, follow us on social media.
